FIELD: medicine.
SUBSTANCE: invention relates to a compound having one of following formulas ND-011544, ND-011598, ND-011622, ND-10885. The invention also relates to a pharmaceutical composition for the treatment of pathological conditions characterized by mycobacterial activity or infection, containing effective amount of a compound according to the invention and a physiologically acceptable carrier.
EFFECT: compounds having mycobacterial activity.
6 cl, 8 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
5,5-HETEROAROMATIC ANTI-INFECTIOUS COMPOUNDS | 2013 |
|
RU2696278C2 |
β-LACTAMYL-SUBSTITUTED ANALOGUES OF PHENYLALANINE, CYSTEINE AND SERINE AS VASOPRESSIN ANTAGONISTS | 2006 |
|
RU2466991C2 |
CYTOTOXIC BENZODIASEPINE DERIVATIVES | 2012 |
|
RU2631498C2 |
THIENO[2,3-d]PYRIMIDINES AS ANTIMICROBIAL AGENTS | 2018 |
|
RU2803136C2 |
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF AND METHODS OF USING SAME | 2010 |
|
RU2608611C2 |
2,5-DISUBSTITUTED ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2527165C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE FOR TREATMENT OF PATHOLOGICAL CONDITIONS | 2017 |
|
RU2773333C2 |
OESTROGEN RECEPTOR MODULATING COMPOUNDS | 2019 |
|
RU2826635C2 |
HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
Authors
Dates
2023-04-10—Published
2016-09-19—Filed